What is the 317 immunization grant program?
An estimated 10 million cases of vaccine preventable diseases and 33,000 deaths are prevented each year through timely immunization. However, on the other side, for those not immunized, approximately 43,000 adults and 300 children in the United States die annually from vaccine-preventable diseases or their complications. Despite high immunization coverage levels for preschool-aged children, pockets of need remain among both children and adults. Additional doses of vaccine are needed to purchase the full series of recommended vaccines for children who are not eligible for the Vaccines for Children program, but go to state and local public health departments for vaccinations. Most children served through Section 317 are under-insured or their parents are working poor who cannot afford the high deductibles or copayments required to fully vaccinate their children. Therefore, many of these children are under-immunized. Similar challenges exist for uninsured or under-insured adults who are recommended to receive vaccines.
Immunization infrastructure is crucial, especially when public health priorities can shift rapidly in the event of an outbreak of a vaccine-preventable disease or a bioterrorism event. Managing immunization resources to deal with urgent events or unanticipated shortages pose challenges to state programs.
Authorized under Section 317 of the Public Health Service Act, federal funding for the 317 grant program was launched in 1963. Forty-two years later, in 2005, CDC awarded $431 million in federal grants to state, local, and territorial public health agencies for program operations and vaccine purchase. Currently there are 64 grantees: all 50 states, six large cities, and eight territories and former territories.
The majority of Section 317 program funds are used by states to conduct routine childhood programs, with a smaller portion remaining for adult immunization programs. Therefore, despite high vaccination coverage levels among preschool-aged children, adult vaccination levels remain considerably lower and racial and ethnic disparities exist.
The Section 317 grant program works to ensure that children, adolescents, and adults receive appropriate immunizations by partnering with healthcare providers in the public and private sectors. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve high immunization coverage, and supports infrastructure for essential activities such as immunization registries, outreach, disease surveillance, outbreak control, education, and service delivery. A strong immunization infrastructure ensures optimal coverage with routinely recommended vaccines.
317 Appropriations Information
FY 2010 General Support Letter
FY 2010 Senate Dear Colleague
FY 2010 CDC Immunization Report to Congress
FY 2009 General Support Letter
FY 2009 317 Coalition Request
FY 2009 CDC President's Budget Congressional Justification
FY 2009 CDC Immunization Report to Congress
FY 2009 Senate Dear Colleague
FY 2009 House Dear Colleague
Immunization Schedules
It is very important to know when your child should be immunized. Please click on the links below for current immunization schedules.
Child Immunization Schedule
Adult Immunization Schedule
MMWR QuickGuide - Recommended Childhood and Adolescent Immunization Schedule
More Resources
Please click on any of the links below to learn more important information about childhood, adolescent, and adult vaccinations.
View the FY 2008 Archives here
View the FY 2007 Archives here
Section 317 Program in Brief
Vaccines For Children Program in Brief
Economic Evaluation of the 7-Vaccine Routine Childhood Immunization Schedule
Childhood Vaccine Doses Distributed by Funding Source
Comparison of 20th Century Estimated Annual Morbidity and Current Reported Morbidity
Number of Vaccines in the Routine Childhood Immunization Schedule
Comparison of Pre-Vaccine Era Estimated Annual Morbidity and Current Estimated Morbidity
Federal Contract Prices for Vaccines Recommended Universally for Children and Adolescents
Number of Children and Adolescents Who Could Potentially Receive Full Series with 317 Funds
Percent Increase of the Cost of Full Series vs. Percent Increase of Appropriation
Cost Effectiveness of Childhood Vaccines
Estimated Vaccination Coverage with the 4:3:1:3:3 Series
Estimated Vaccination Coverage with 3+ PCV, by Coverage and by State
Percentage of Adults Receiving Influenza Vaccine, 2004
Percentage of Adults Receiving Pneumococcal Vaccine Ever, 2004